Morphic Holding Stock

Morphic Holding Equity 2025

Morphic Holding Equity

697.02 M USD

Ticker

MORF

ISIN

US61775R1059

WKN

A2PLX9

In 2025, Morphic Holding's equity was 697.02 M USD, a 99.66% increase from the 349.1 M USD equity in the previous year.

Morphic Holding Aktienanalyse

What does Morphic Holding do?

Morphic Holding Inc. is a pharmaceutical company that focuses on developing therapies for serious diseases. The company was founded in 2015 and is based in Waltham, Massachusetts. The company's business model is centered around developing drugs based on "Morphic Molecules" that are specifically designed to interact with certain target proteins in the body. These molecules aim to improve the treatment of diseases such as autoimmune diseases and fibrosis. Morphic Holding Inc. collaborates closely with leading scientists in the field of structural biology to develop new therapy options for patients. The company has formed partnerships with Biogen, Janssen Biotech, and AbbVie to collaboratively develop new medications. In addition to partnering with other leading companies in the healthcare industry, Morphic Holding Inc. also maintains its own research department focused on the discovery and development of new compounds. The company has applied for and been granted several patents for its "Morphic Molecules," further strengthening its ability to develop innovative therapies for serious diseases. One of Morphic Holding Inc.'s current products is a drug for the treatment of cystic fibrosis that is still in the development phase. The company is working to advance its research and development in this area to continue offering innovative therapies for patients. Morphic Holding Inc. is also involved in biotechnological development and offers services to assist other companies in developing new compounds. These services include the identification and validation of target proteins, the design and synthesis of molecules, and the optimization of drug properties. In conclusion, Morphic Holding Inc. is an emerging force in the pharmaceutical development field. The company has a unique approach to drug development and has already established partnerships with other companies and leading research institutions to develop new therapy options for patients. With its commitment to innovation and research, Morphic Holding Inc. is likely to continue making significant advancements in the field of medicine in the future. Morphic Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Morphic Holding's Equity

Morphic Holding's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Morphic Holding's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Morphic Holding's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Morphic Holding's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Morphic Holding’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Morphic Holding stock

What is the equity of Morphic Holding this year?

Morphic Holding has equity of 697.02 M USD this year.

What was the equity of Morphic Holding compared to the previous year?

The equity of Morphic Holding has increased/decreased by 99.66% increased compared to the previous year.

What impact does a high equity have on investors of Morphic Holding?

A high equity is advantageous for investors of Morphic Holding as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Morphic Holding?

A low equity can be a risk for investors of Morphic Holding, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Morphic Holding affect the company?

An increase in equity of Morphic Holding can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Morphic Holding affect the company?

A reduction in equity of Morphic Holding can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Morphic Holding?

Some factors that can affect the equity of Morphic Holding include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Morphic Holding so important for investors?

The equity of Morphic Holding is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Morphic Holding take to change the equity?

To change equity, Morphic Holding can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Morphic Holding pay?

Over the past 12 months, Morphic Holding paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Morphic Holding is expected to pay a dividend of 0 USD.

What is the dividend yield of Morphic Holding?

The current dividend yield of Morphic Holding is .

When does Morphic Holding pay dividends?

Morphic Holding pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Morphic Holding?

Morphic Holding paid dividends every year for the past 0 years.

What is the dividend of Morphic Holding?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Morphic Holding located?

Morphic Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von Morphic Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Morphic Holding from 8/3/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/3/2025.

When did Morphic Holding pay the last dividend?

The last dividend was paid out on 8/3/2025.

What was the dividend of Morphic Holding in the year 2024?

In the year 2024, Morphic Holding distributed 0 USD as dividends.

In which currency does Morphic Holding pay out the dividend?

The dividends of Morphic Holding are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Morphic Holding

Our stock analysis for Morphic Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Morphic Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.